New cancer clinical trial: Dynamics of 18-FDG Uptake in Stage III/IV Non Small Cell Lung Cancer During First Line Pembrolizumab Treatment

Published on: February 06, 2019 at 10:30PM

• Tweet
• Share
• Share
• Share
• Share